UK ENcorafenib and BInimetinib Real-world Study in Melanoma
UK ENcorafenib and BInimetinib Real-world Study in Melanoma
Active, not recruiting · NCT07022457 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| UK ENcorafenib and BInimetinib Real-world Study in Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Not stated | 2026-04-13 | NCT07022457 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pierre Fabre Ltd | 1 |
| Vitaccess Ltd | 4 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Addenbrookes Hospital | Cambridge | United Kingdom | 1 |
| Queen Elizabeth Hospital | Birmingham | United Kingdom | 1 |
| Royal Marsden Hospital | London | United Kingdom | 3 |
| Royal Preston Hospital | Preston | United Kingdom | 1 |
| Southampton General Hospital | Southampton | United Kingdom | 2 |
| Southend University Hospital | Westcliff-on-Sea | United Kingdom | 1 |
| University Hospital Coventry and Warwickshire | Coventry | United Kingdom | 1 |